Express Pharma - Express Pharma

Vishal Goel, Managing Director, RX Propellant highlights that by fostering collaboration, nurturing talent, and addressing key…

Revenue growth to moderate to 8-10 per cent in FY2025, post a healthy 13-14 per cent YoY expansion in FY2024

Dr. Satish Wagh, Chairman & MD, Supriya Lifescience speaks to Express Pharma on the company's strategy to achieve a…

Veeda expands its reach to major geographies and adds capabilities of late-stage clinical trial execution with strong focus on…

Additional indications for treatment of HER2 low breast cancer and HER2 positive gastric / gastro-oesophageal cancer

Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium

Chandru Chawla, a pharma veteran writes an open letter to those CEOs of Pharmaceutical companies who have NOT purchased Electoral…

First live equity-for-investment bidding, for funding upto Rs 5 Crore/USD 540,000 for nutraceuticals innovators, will be streamed…

Under the terms of the agreement, Univercells will test in vitro and in vivo a proprietary mRNA vaccine delivered with Altamira’s…

The agreement includes Cardior’s lead compound CDR132L, currently in phase 2 clinical development for the treatment of heart…